US Patent 7943298 Prevention and treatment of sub-clinical PCVD

Patent 7943298 was granted and assigned to Boehringer Ingelheim on May, 2011 by the United States Patent and Trademark Office.

Overview Structured Data Issues Contributors Activity

Is a

Patent

Patent attributes

Current Assignee

Boehringer Ingelheim

Patent Jurisdiction

United States Patent and Trademark Office

Patent Number

7943298

Date of Patent

May 17, 2011

Patent Application Number

12030611

Date Filed

February 13, 2008

Patent Citations Received

‌

US Patent 11858963 PCV2 ORF2 protein variant and virus like particles composed thereof

Patent Primary Examiner

‌

Ali R. Salimi

Patent abstract

The present invention relates to the use of an immunogenic composition comprising a porcine circovirus type 2 (PCV2) antigen for the prevention and treatment of sub-clinical PCV2 infection in animals, preferably in pigs.

Timeline

No Timeline data yet.

Further Resources

Title

Author

Link

Type

Date

No Further Resources data yet.

References

Find more entities like US Patent 7943298 Prevention and treatment of sub-clinical PCVD

Use the Golden Query Tool to find similar entities by any field in the Knowledge Graph, including industry, location, and more.

Open Query Tool

Access by API